Effect of a switch of aromatase inhibitors to another aromatase inhibitor or tamoxifen on musculoskeletal symptoms in breast cancer; Which is the best?

被引：0
|
作者：
Altundag, Kadri [1 ]
机构：
[1] MKA Breast Canc Clin, Ankara, Turkey
来源：
JOURNAL OF BUON | 2020年 / 25卷 / 04期
关键词：
MANAGEMENT;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2132 / 2133
页数：2
相关论文
共 50 条
  • [21] Tamoxifen resistant and refractory breast cancer - The value of aromatase inhibitors
    Goss, PE
    Strasser, K
    DRUGS, 2002, 62 (06) : 957 - 966
  • [22] Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer
    Haque, Reina
    Ahmed, Syed A.
    Fisher, Alice
    Avila, Chantal C.
    Shi, Jiaxiao
    Guo, Amy
    Cheetham, T. Craig
    Schottinger, Joanne E.
    CANCER MEDICINE, 2012, 1 (03): : 318 - 327
  • [23] Compliance and persistence of tamoxifen and aromatase inhibitors in breast cancer patients
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 96 - 97
  • [24] Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer
    Wenjie Jessie Lu
    Zeruesenay Desta
    David A. Flockhart
    Breast Cancer Research and Treatment, 2012, 131 : 473 - 481
  • [25] Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer
    Lu, Wenjie Jessie
    Desta, Zeruesenay
    Flockhart, David A.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) : 473 - 481
  • [26] Switch to aromatase inhibitor better than continuing tamoxifen
    不详
    CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (06) : 330 - 331
  • [27] Musculoskeletal complications and aromatase inhibitors in adjuvant breast cancer treatment
    Khalifa, P.
    Lesur, A.
    ONCOLOGIE, 2007, 9 : HS5 - HS10
  • [28] Factors associated with aromatase inhibitor associated musculoskeletal symptoms in early stage breast cancer patients
    Sun, Yamin
    Elder, Simran
    Jung, Seungyoun
    Mainor, Candace
    Murali, Shruti
    Rosenblatt, Paula
    Tkaczuk, Katherine
    CANCER RESEARCH, 2020, 80 (04)
  • [29] Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
    Henry, N. Lynn
    Giles, Jon T.
    Ang, Dennis
    Mohan, Monika
    Dadabhoy, Dina
    Robarge, Jason
    Hayden, Jill
    Lemler, Suzanne
    Shahverdi, Karineh
    Powers, Penny
    Li, Lang
    Flockhart, David
    Stearns, Vered
    Hayes, Daniel F.
    Storniolo, Anna Maria
    Clauw, Daniel J.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 111 (02) : 365 - 372
  • [30] Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
    N. Lynn Henry
    Jon T. Giles
    Dennis Ang
    Monika Mohan
    Dina Dadabhoy
    Jason Robarge
    Jill Hayden
    Suzanne Lemler
    Karineh Shahverdi
    Penny Powers
    Lang Li
    David Flockhart
    Vered Stearns
    Daniel F. Hayes
    Anna Maria Storniolo
    Daniel J. Clauw
    Breast Cancer Research and Treatment, 2008, 111 : 365 - 372
12345